Stockscreener 앱 받기
462.60
1.41%
-6.61
시간 외 거래:
461.60
-1.00
-0.22%
전일 마감가:
$469.21
열려 있는:
$466.98
하루 거래량:
1.78M
Relative Volume:
0.81
시가총액:
$171.91B
수익:
$45.20B
순이익/손실:
$6.87B
주가수익비율:
25.43
EPS:
18.1888
순현금흐름:
$6.75B
1주 성능:
-1.16%
1개월 성능:
-5.87%
6개월 성능:
-18.16%
1년 성능:
+9.22%
1일 변동 폭
$461.90
$470.39
1주일 범위
$461.00
$481.83
52주 변동 폭
$385.46
$643.99
써모 피셔 사이언티픽 Stock (TMO) Company Profile
명칭
Thermo Fisher Scientific Inc
전화
(781) 622-1000
주소
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, NTRA
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
462.60 | 174.37B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
174.04 | 123.97B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
563.12 | 45.07B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
112.18 | 32.36B | 7.07B | 1.29B | 993.00M | 4.5355 |
NTRA
Natera Inc
|
211.56 | 29.60B | 2.31B | -208.16M | 76.11M | -1.5366 |
써모 피셔 사이언티픽 Stock (TMO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-27 | 개시 | DZ Bank | Buy |
| 2025-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-12-09 | 개시 | Goldman | Buy |
| 2025-12-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | 재개 | Morgan Stanley | Overweight |
| 2025-12-01 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2025-09-11 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2025-08-19 | 개시 | William Blair | Outperform |
| 2025-07-24 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-07-11 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | 다운그레이드 | UBS | Buy → Neutral |
| 2025-01-10 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | 개시 | Scotiabank | Sector Perform |
| 2024-10-14 | 개시 | Redburn Atlantic | Buy |
| 2024-10-01 | 개시 | Stephens | Overweight |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-03-18 | 재개 | Citigroup | Neutral |
| 2024-01-24 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2024-01-08 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | 개시 | HSBC Securities | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-10-26 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-09-06 | 재개 | Citigroup | Buy |
| 2023-07-19 | 개시 | Raymond James | Outperform |
| 2023-07-19 | 재확인 | Robert W. Baird | Outperform |
| 2023-07-13 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | 재확인 | Barclays | Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-10-27 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 개시 | Credit Suisse | Neutral |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | 재개 | Barclays | Overweight |
| 2021-10-20 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-16 | 개시 | The Benchmark Company | Buy |
| 2021-03-18 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2021-01-08 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-12-02 | 개시 | Goldman | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-09-14 | 개시 | Morgan Stanley | Overweight |
| 2020-08-20 | 재개 | JP Morgan | Overweight |
| 2020-07-15 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2020-07-07 | 재확인 | Needham | Buy |
| 2020-04-23 | 재확인 | Needham | Buy |
| 2020-01-31 | 재확인 | Needham | Buy |
| 2020-01-22 | 개시 | Credit Suisse | Neutral |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-07-25 | 재확인 | Needham | Buy |
| 2019-07-16 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-05-30 | 개시 | Wolfe Research | Outperform |
| 2019-05-23 | 재확인 | Needham | Strong Buy |
| 2019-04-22 | 재확인 | Needham | Strong Buy |
| 2019-04-16 | 재확인 | BofA/Merrill | Buy |
모두보기
써모 피셔 사이언티픽 주식(TMO)의 최신 뉴스
Global Plasmid DNA Manufacturing Market Anticipates Impressive Growth Trajectory at a CAGR of ~18% by 2034 | DelveInsight - GlobeNewswire Inc.
Thermo Fisher Scientific Introduces Gibco CTS DynaXS Single Use Bioreactor - Contract Pharma
International Markets and Thermo Fisher (TMO): A Deep Dive for Investors - Yahoo Finance
Thermo Fisher Introduces Gibco CTS DynaXS Single Use Bioreactor For Scalable Cell Therapy Manufacturing - BioPharma APAC
Thermo Fisher Scientific Unveils an Integrated Platform to Advance Scalable Cell Therapy Manufacturing - FinancialContent
What Is Thermo Fisher Scientific Inc.'s (NYSE:TMO) Share Price Doing? - Yahoo Finance
Thermo Fisher's $1.08B Microbiology Sell-Off: A Procurement and Operations Briefing for Lab Managers - Lab Manager
Sandro Wealth Management LLC Makes New $2.09 Million Investment in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Q1 2026 Financial Results and SEC 10-Q Filing Summary - Minichart
Thermo Fisher Scientific Inc. stock falls Friday, underperforms market - MarketWatch
Argus Adjusts Price Target on Thermo Fisher Scientific to $560 From $610 - marketscreener.com
Billionaire Investor Takes New Stake In Thermo Fisher Scientific - Yahoo Finance
Thermo Fisher (NYSE: TMO) grows Q1 revenue and closes $9.1B Clario deal - Stock Titan
Thermo Fisher Scientific Inc. $TMO Shares Sold by Danica Pension Livsforsikringsaktieselskab - MarketBeat
How Investors Are Reacting To Thermo Fisher Scientific (TMO) Expanding Its U.S. Bioprocess Design Center - Yahoo Finance
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MarketWatch
Argus Cuts Price Target on Thermo Fisher Scientific to $560 From $610 - marketscreener.com
Vanguard (NYSE: TMO) reports 28.0M shares of Thermo Fisher, 7.53% stake - Stock Titan
Thermo Fisher Scientific opens bioprocess design center in Massachusetts - chemengonline.com
Soil Testing Equipment Market Size, Share & Growth Outlook - openPR.com
Thermo Fisher Scientific Agrees to Divest Its Microbiology Business to Astorg - ChemAnalyst
PowerFlex thermal cycler boosts PCR flexibility & speed - SelectScience
Molecular Quality Controls Market | THERMO FISHER SCIENTIFIC, INC, Qnostics, Zeptometrix Corporation etc. - openPR.com
Insider Sell: Gianluca Pettiti Sells Shares of Thermo Fisher Sci - GuruFocus
Thermo Fisher Scientific Experiences Valuation Adjustment Amid Competitive Market Landscape - Markets Mojo
Thermo Fisher Scientific president & COO sells $185,064 in stock - Investing.com
Thermo Fisher Scientific president & COO sells $185,064 in stock By Investing.com - Investing.com UK
Thermo Fisher Scientific (NYSE:TMO) COO Sells $185,064.00 in Stock - MarketBeat
Thermo Fisher (NYSE: TMO) COO executes 400-share Rule 10b5-1 sale - Stock Titan
Thermo Fisher Scientific to sell its microbiology business as Astorg - chemengonline.com
Thermo Fisher Scientific launches applied Biosystems PowerFlex Thermal Cycler - Med-Tech Insights
Thermo Fisher Scientific, SHL Medical Collaborate on Integrated Drug-Device Solutions - Medical Product Outsourcing
Do You Believe in The Long-Term Growth Outlook of Thermo Fisher Scientific (TMO)? - Insider Monkey
Thermo Fisher Scientific Opens U.S. Flagship Bioprocess Design Center to Accelerate the Delivery of Life-changing Therapies - BioSpace
Thermo Fisher Scientific to Host Investor DayApril 28, 2026 - BioSpace
Thermo Fisher to Sell Microbiology Business to Astorg - WSJ
Thermo Fisher opens Plainville design center amid $2B push for U.S. manufacturing - The Business Journals
Thermo Fisher sells microbiology business for $1B - BioWorld News
Thermo Fisher agrees to sell microbiology business to Astorg in $1bn deal - Medical Device Network
Thermo Fisher Scientific Opens U.S. Flagship Bioprocess Design Center to Accelerate the Delivery of - PharmiWeb.com
Thermo Fisher inks $1.1B deal to sell microbiology unit to Astorg - MedTech Dive
Thermo Fisher Scientific Opens Flagship U.S. Bioprocess Design Center in MA - Contract Pharma
Thermo Fisher Stock Fell After Q1 2026 Earnings. Is TMO a Buy? - TIKR.com
Medical Refrigerators Market Competitive Analysis to 2028 | - openPR.com
Thermo Fisher drops despite Q1 beat, guidance hike - MSN
Thermo Fisher sells microbiology biz to Astorg for $1.075 B - BioSpectrum Asia
Thermo Fisher Scientific Signs Agreement to Sell its Microbiology Business to Astorg - BioSpace
Thermo Fisher to divest microbiology business in $1.07 billion deal with PE firm Astorg - DOTmed
Thermo Fisher sells microbiology business to private equity firm for $1B - The Business Journals
Thermo Fisher to sell microbiology business to PE firm Astorg for over $1 billion - MSN
Thermo Fisher Scientific Inc (TMO) Stock Price, Trades & News - GuruFocus
써모 피셔 사이언티픽 (TMO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.63%
2.06%
자본화:
|
볼륨(24시간):